The prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma

HIGHLIGHTS

  • who: Andreea Ioana Parosanu et al. from the Department of Medical Oncology, Elias Emergency University Hospital, Bucharest, Romania have published the paper: The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma, in the Journal: (JOURNAL) of 31/Oct/2022
  • what: A survival prognosis is essential but very challenging.
  • how: The results indicated that an elevated pre-treatment NLR of u22653 was significantly associated with poorer OS and DFS (HR=2.31 95% p and amplt 0.001) .
  • future: A more extensive prospective study is needed . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?